Icon Oncology Group and Nuffield Health announce three new cancer centres in the UK
Icon Oncology Group and Nuffield Health are expanding our partnership with the development of three new Icon Cancer Centre sites adjacent to Nuffield Health Brighton Hospital, Nuffield Health Derby Hospital, and Nuffield Health Warwickshire Hospital.
Nuffield Health
In 2023, Nuffield Health and Icon Oncology Group entered into a strategic partnership, sharing a common mission to expand access to high-quality care. This collaboration began with Cancer Centre London in Wimbledon and continues to explore new cancer care service opportunities across the network.
Together, Icon Cancer Centre and Nuffield have a mission to create a comprehensive care pathway, supporting patients from prevention and early detection to exceptional treatment and after-care care for cancer patients. Read the latest update.
Pharmaxo Group
In August 2024, Icon Oncology Group announced the acquisition of Pharmaxo Group (Pharmaxo), which includes Bath ASU, Pharmaxo Healthcare and Pharmaxo Scientific. Based in Corsham, Wiltshire, Pharmaxo is a leading pharmaceutical specialist manufacturer and clinical homecare provider.
This acquisition marked Icon Cancer Centre's entry into compounding and pharmaceutica in the United Kingdom, reinforcing its commitment to improving healthcare in the region.
Icon Cancer Centre's collaboration with Pharmaxo complements its strategic partnership with Nuffield Health, further expanding cancer treatment capacity to under-served communities across the UK. Read the latest update
Global Partnerships
Icon Cancer Centre invests in strong industry partnerships so we can deliver the best care possible, to as many people as possible, as close to home as possible around the world.
Our valued partners include:
City Cancer Challenge Foundation (C/Can)
Union for International Cancer Control
Varian Medical Systems
International Hospital Federation